Oxygen Biotherapeutics (OXBT)
Create an Alert
3.22
+0.46 +16.67%
NASDAQ
Jun 19, 5:01PM
BATS Real time
Currency in USD
Oxygen Biotherapeutics Cash from Operations Quarterly:
-0.739M for Jan. 31, 2013Oxygen Biotherapeutics Historical Cash from Operations Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Jan. 31, 2013 | -0.739M |
| Oct. 31, 2012 | -1.129M |
| July 31, 2012 | -1.613M |
| April 30, 2012 | -1.421M |
| Jan. 31, 2012 | -2.274M |
| Oct. 31, 2011 | -2.530M |
| July 31, 2011 | -2.054M |
| April 30, 2011 | -1.751M |
| Jan. 31, 2011 | -2.263M |
| Oct. 31, 2010 | -1.776M |
| July 31, 2010 | -2.613M |
| April 30, 2010 | -2.293M |
| Jan. 31, 2010 | -3.461M |
| Oct. 31, 2009 | -1.305M |
| July 31, 2009 | -1.528M |
| April 30, 2009 | -1.337M |
| Jan. 31, 2009 | -0.9559M |
| Oct. 31, 2008 | -0.8902M |
| July 31, 2008 | -0.8742M |
| April 30, 2008 | Go Pro |
| Jan. 31, 2008 | Go Pro |
| Oct. 31, 2007 | Go Pro |
| July 31, 2007 | Go Pro |
| April 30, 2007 | Go Pro |
| Jan. 31, 2007 | Go Pro |
| Oct. 31, 2006 | Go Pro |
| July 31, 2006 | Go Pro |
| April 30, 2006 | Go Pro |
| Jan. 31, 2006 | Go Pro |
| Oct. 31, 2005 | Go Pro |
| July 31, 2005 | Go Pro |
| April 30, 2005 | Go Pro |
| Jan. 31, 2005 | Go Pro |
| Oct. 31, 2004 | Go Pro |
| July 31, 2004 | Go Pro |
| April 30, 2004 | Go Pro |
| Jan. 31, 2004 | Go Pro |
| Oct. 31, 2003 | Go Pro |
| July 31, 2003 | Go Pro |
| April 30, 2003 | Go Pro |
| Jan. 31, 2003 | Go Pro |
| Oct. 31, 2002 | Go Pro |
| July 31, 2002 | Go Pro |
| April 30, 2002 | Go Pro |
| Jan. 31, 2002 | Go Pro |
| Oct. 31, 2001 | Go Pro |
| July 31, 2001 | Go Pro |
| April 30, 2001 | Go Pro |
| Jan. 31, 2001 | Go Pro |
| Oct. 31, 2000 | Go Pro |
About Cash From Operations
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.
Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
Learn More
OXBT Cash from Operations Quarterly Benchmarks
| Companies | |
|---|---|
| Opexa Therapeutics | 3.039M |
| ARCA biopharma | -0.764M |
| Clinuvel Pharmaceuticals |
OXBT Cash from Operations Quarterly Rankings
| Overall |
62nd percentile 6360 of 16782 |
| Sector |
63rd percentile 518 of 1410 in Healthcare |
| Industry |
74th percentile 116 of 454 in Biotechnology |
OXBT Cash from Operations Quarterly Range, Past 5 Years
| Minimum | -3.461M | Jan 2010 |
| Maximum | -0.7390M | Jan 2013 |
| Average | -1.727M |
